Use of polydeoxyribonucleotides in diabetic neuropathies

Details Use of polydeoxyribonucleotides in diabetic neuropathies Use of polydeoxyribonucleotides in diabetic neuropathies

1995-07-21

1997-10-14

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

424451, 424464, 424489, 514866, A61F 200, A61K 916, A61K 920, A61K 948

Patent

active

056769652

ABSTRACT:
A pharmaceutical composition comprising a polydeoxyribonucleotide of random sequence formula is disclosed, and

REFERENCES:
patent: 5223609 (1993-06-01), Fedeli et al.
Y. Okamiya et al., "Antihypertensive Effect of the New Calcium Antagonist (.+-.)-3(Benzylmethylamino)-2,2-dimethylpropyl-methyl-4-(2-fluoro-5-Nitrop henyl)-1,4-dihydro-2,6-dimethyl3,5-pyridinedicarboxylate Hydrochloride in Rats", Dept. of Pharmacology, Teijin Institute for Bio-Medical Research II, Tokyo (Japan) 1992.
Mark A. Yorek et al., "Restoration of Na.sup.+ -K.sup.+ Pump Activity and Resting Membrane Potential by myo-Inositol Supplementation in Neuroblastoma Cells Chronically Exposed to Glucose or Galactose", Diabetes, vol. 40, Feb. 1991.

Affiliated with

Also associated with

Rating

Use of polydeoxyribonucleotides in diabetic neuropathies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of polydeoxyribonucleotides in diabetic neuropathies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of polydeoxyribonucleotides in diabetic neuropathies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1553189